FDA Starts Publishing List of Drugs Under Suspicion
In an attempt to get information to the public at an earlier stage than ever before, the Federal Drug Administration (“FDA”) has announced that it will post a listing every three months of the prescription drugs which are being investigated by the FDA. The listing will be posted on the FDA’s Web site. The first list can be found below.
While inclusion on the listing will not mean that a drug is dangerous, it does mean it is under investigation and this step of informing the public is quite an improvement in open government. People should not panic if they are taking a drug that is on the list, but they should be aware of the reported side affects and talk to their doctor about it. Plus, each person should monitor their own health closely if they are taking a drug on this list or any future list published by the FDA.
I know all too well from representing many families where a loved one was injured or died from taking a dangerous drug that sometimes the risk benefit of taking these drugs is just not worth it. I don’t trust drug companies and I know first hand that they can sometimes put profits over people. Just recently I wrote in Dangerous Drug Vioxx Had Misleading Study about the initial Vioxx study that was for marketing purposes instead of safety reasons like Merck had reported.
Here is the first listing of drugs under investigation and the potential problems of the drugs:
Arginine Hydrochloride Injection (R-Gene 10)---Pediatric overdose due to labeling / packaging confusion
Desflurane (Suprane) Cardiac arrest
Duloxetine (Cymbalta) Urinary retention
Etravirine (Intelence) Hemarthrosis
Fluorouracil Cream (Carac) and Ketoconazole Cream (Kuric) Adverse events due to name confusion
Heparin---Anaphylactic-type reactions
Icodextrin (Extraneal)---Hypoglycemia
Insulin U-500 (Humulin R)---Dosing confusion
Ivermectin (Stromectol) and Warfarin---Drug interaction
Lapatinib (Tykerb)---Hepatotoxicity
Lenalidomide (Revlimid)---Stevens Johnson Syndrome
Natalizumab (Tysabri)---Skin melanomas
Nitroglycerin (Nitrostat)---Overdose due to labeling confusion
Octreotide Acetate Depot (Sandostatin LAR)---Ileus
Oxycodone Hydrochloride Controlled-Release (Oxycontin)---Drug misuse, abuse and overdose
Perflutren Lipid Microsphere (Definity)---Cardiopulmonary reactions
Phenytoin Injection (Dilantin)---Purple Glove Syndrome
Quetiapine (Seroquel)---Overdose due to sample pack labeling confusion
Telbivudine (Tyzeka)---Peripheral neuropathy
Tumor Necrosis Factor (TNF) Blockers---Cancers in children and young adults
